Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Xth Eurasian Hematology-Oncology Congress
S

Optimizing Therapy for ER+ Metastatic Breast Cancer: CDK 4/6 + Endocrine Therapy as 1st Line, Everolimus-Exemestane PI3K as a Reasonable Options for Mutant Patients

By Xth Eurasian Hematology-Oncology Congress FEATURING Sema Sezgin Göksu
By Xth Eurasian Hematology-Oncology Congress FEATURING Sema Sezgin Göksu
101 views
December 4, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Breast
06:46

Systemic Therapy in Early HER2+ Breast Cancer: More Benefit w/Neoadj…

Xth Eurasian Hematology-Oncology Congress

C. Arslan

137 views
23:24

Systemic Adjuvant Therapy in Early HER2+ Breast Cancer: Escalating w…

Xth Eurasian Hematology-Oncology Congress

C. Arslan

174 views
09:24

Evolving Approaches in Systemic Therapy for TNBC in Adjuvant Setting…

Xth Eurasian Hematology-Oncology Congress

O. Er

319 views
23:29

Systemic Therapy for TNBC in Neoadjuvant Setting: Initial Treatment …

Xth Eurasian Hematology-Oncology Congress

O. Er

240 views
32:43

Adjuvant Therapy in ER+ / HER2- Early Breast Cancer: Is Chemotherapy…

Xth Eurasian Hematology-Oncology Congress

M. Kaplan

72 views
15:29

Optimizing Therapy for ER+ Metastatic Breast Cancer: CDK 4/6 + Endoc…

Xth Eurasian Hematology-Oncology Congress

S. Göksu

101 views
10:36

Overcoming Resistance in HER2+ Metastatic Breast Cancer: Single Anti…

Xth Eurasian Hematology-Oncology Congress

S. Uzunoğlu

58 views
13:37

Overcoming Resistance in HER2+ Metastatic Breast Cancer: Inhibiting …

Xth Eurasian Hematology-Oncology Congress

S. Uzunoğlu

97 views
18:51

PARPi as the Emerging Treatment Strategy in BRCA+ Metastatic TNBC: I…

Xth Eurasian Hematology-Oncology Congress

O. Dizdar

63 views